ETFs North China Pharmaceutical Company.Ltd

600812

CNE000000D16

Pharmaceuticals

End-of-day quote Shanghai S.E. 2026-09-30			5-day change	1st Jan Change
4.980 ^CNY	+2.89%		+2.05%	-9.95%

09-21	North China Pharmaceutical Company.Ltd(XSSC:600812) dropped from FTSE All-World Index	CI
08-21	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2026	CI

ETFs positioned on North China Pharmaceutical Company.Ltd

Name	YTD change	Weight	AuM
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	+6.55%	-.--%	37 M€
DIMENSIONAL EMERGING MARKETS CORE EQUITY 2 ETF - USD	+21.86%	-.--%	9,273 M€
INVESCO FTSE ALL-WORLD UCITS ETF DIST - USD	+16.38%	0%	331 M€
INVESCO FTSE ALL-WORLD UCITS ETF - CHF HEDGED	+10.55%	0%	81 M€
INVESCO FTSE ALL-WORLD UCITS ETF PFHDG DIST - GBP HEDGED	+12.48%	0%	31 M€
VANGUARD FTSE EMERGING MARKETS UCITS ETF - USD	+10.52%	0%	3,667 M€
INVESCO FTSE ALL-WORLD UCITS ETF PFHDG ACC- EUR HEDGED	+12.35%	0%	69 M€
VANGUARD FTSE EMERGING MARKETS UCITS ETF ACCUMULATING - USD	+15.08%	0%	2,339 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF ACC - USD	+19.41%	0%	117 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF DIST - USD	+17.51%	0%	24 M€
VANGUARD FTSE EMERGING MARKETS ALL CAP INDEX ETF - CAD	+14.91%	0%	3,276 M€
VANGUARD FTSE EMERGING MARKETS ETF - USD	+10.79%	0%	126,032 M€
VANGUARD FTSE EMERGING MARKETS SHARES ETF - AUD	+4.62%	0%	1,449 M€
VANGUARD TOTAL INTERNATIONAL STOCK ETF - USD	+13.24%	0%	163,510 M€
VANGUARD FTSE ALL-WORLD EX-US ETF - USD	+13.44%	0%	70,454 M€
ELM MARKET NAVIGATOR ETF - USD	+7.56%	0%	594 M€
VANGUARD FTSE GLOBAL ALL CAP EX CANADA INDEX ETF - CAD	+16.96%	0%	2,612 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD	+16.64%	0%	12,086 M€
DEFINED DURATION 20 ETF - USD	+11.23%	0%	19 M€
RETURN STACKED GLOBAL STOCKS & BONDS ETF - USD	+6.44%	0%	526 M€
RPAR RISK PARITY ETF - USD	-1.45%	0%	580 M€
CCM GLOBAL EQUITY ETF - USD	+11.84%	0%	1,199 M€
THE BRINSMERE FUND GROWTH ETF - USD	+9.01%	0%	391 M€
UPAR ULTRA RISK PARITY ETF - USD	-3.43%	0%	59 M€
VANGUARD GROWTH ETF PORTFOLIO - CAD	+11.58%	0%	7,793 M€
VANGUARD BALANCED ETF PORTFOLIO - CAD	+7.55%	0%	4,204 M€
DISCIPLINE FUND ETF - USD	-.--%	0%	73 M€
WARREN STREET GLOBAL EQUITY ETF - USD	+13.59%	0%	62 M€
THE BRINSMERE FUND CONSERVATIVE ETF - USD	+2.34%	0%	363 M€
VANGUARD RETIREMENT INCOME ETF PORTFOLIO - CAD	+1.31%	0%	267 M€
CLEARSHARES OCIO ETF - DISTRIBUTING - USD	+9.69%	0%	176 M€
VANGUARD CONSERVATIVE ETF PORTFOLIO - CAD	+3.60%	0%	688 M€
VANGUARD CONSERVATIVE INCOME ETF PORTFOLIO - CAD	-0.26%	0%	184 M€
CAMBRIA GLOBAL EW ETF - USD	+7.18%	0%	146 M€
ACTIVEPASSIVE INTERNATIONAL EQUITY ETF - USD	+8.67%	0%	1,166 M€
CAMBRIA ENDOWMENT STYLE ETF - USD	+10.44%	0%	156 M€
ALPHA ARCHITECT US EQUITY 2 ETF - USD	+12.24%	-.--%	513 M€

North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.

Employees

9,972

Sector

Pharmaceuticals

Calendar

10-28 Earnings release - Q3 2026

More about the company